Literature DB >> 29414935

Selective enhancer changes in osteosarcoma lung metastasis.

Heinrich Kovar1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29414935     DOI: 10.1038/nm.4487

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Modeling metastasis biology and therapy in real time in the mouse lung.

Authors:  Arnulfo Mendoza; Sung-Hyeok Hong; Tanasa Osborne; Mohammed A Khan; Kirk Campbell; Joseph Briggs; Ananth Eleswarapu; Lauren Buquo; Ling Ren; Stephen M Hewitt; El Habib Dakir; El-H Dakir; Susan Garfield; Renard Walker; Glenn Merlino; Jeffrey E Green; Kent W Hunter; Lalage M Wakefield; Chand Khanna
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 2.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

4.  Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.

Authors:  Jae-Seok Roe; Chang-Il Hwang; Tim D D Somerville; Joseph P Milazzo; Eun Jung Lee; Brandon Da Silva; Laura Maiorino; Hervé Tiriac; C Megan Young; Koji Miyabayashi; Dea Filippini; Brianna Creighton; Richard A Burkhart; Jonathan M Buscaglia; Edward J Kim; Jean L Grem; Audrey J Lazenby; James A Grunkemeyer; Michael A Hollingsworth; Paul M Grandgenett; Mikala Egeblad; Youngkyu Park; David A Tuveson; Christopher R Vakoc
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

5.  Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis.

Authors:  Oliver G McDonald; Xin Li; Tyler Saunders; Rakel Tryggvadottir; Samantha J Mentch; Marc O Warmoes; Anna E Word; Alessandro Carrer; Tal H Salz; Sonoko Natsume; Kimberly M Stauffer; Alvin Makohon-Moore; Yi Zhong; Hao Wu; Kathryn E Wellen; Jason W Locasale; Christine A Iacobuzio-Donahue; Andrew P Feinberg
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

6.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.

Authors:  Alvin P Makohon-Moore; Ming Zhang; Johannes G Reiter; Ivana Bozic; Benjamin Allen; Deepanjan Kundu; Krishnendu Chatterjee; Fay Wong; Yuchen Jiao; Zachary A Kohutek; Jungeui Hong; Marc Attiyeh; Breanna Javier; Laura D Wood; Ralph H Hruban; Martin A Nowak; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

Review 7.  Functions of AP1 (Fos/Jun) in bone development.

Authors:  E F Wagner
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.

Authors:  Nathan C Sheffield; Gaelle Pierron; Johanna Klughammer; Paul Datlinger; Andreas Schönegger; Michael Schuster; Johanna Hadler; Didier Surdez; Delphine Guillemot; Eve Lapouble; Paul Freneaux; Jacqueline Champigneulle; Raymonde Bouvier; Diana Walder; Ingeborg M Ambros; Caroline Hutter; Eva Sorz; Ana T Amaral; Enrique de Álava; Katharina Schallmoser; Dirk Strunk; Beate Rinner; Bernadette Liegl-Atzwanger; Berthold Huppertz; Andreas Leithner; Gonzague de Pinieux; Philippe Terrier; Valérie Laurence; Jean Michon; Ruth Ladenstein; Wolfgang Holter; Reinhard Windhager; Uta Dirksen; Peter F Ambros; Olivier Delattre; Heinrich Kovar; Christoph Bock; Eleni M Tomazou
Journal:  Nat Med       Date:  2017-01-30       Impact factor: 53.440

9.  Genome-wide chromatin state transitions associated with developmental and environmental cues.

Authors:  Jiang Zhu; Mazhar Adli; James Y Zou; Griet Verstappen; Michael Coyne; Xiaolan Zhang; Timothy Durham; Mohammad Miri; Vikram Deshpande; Philip L De Jager; David A Bennett; Joseph A Houmard; Deborah M Muoio; Tamer T Onder; Ray Camahort; Chad A Cowan; Alexander Meissner; Charles B Epstein; Noam Shoresh; Bradley E Bernstein
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

10.  Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.

Authors:  James J Morrow; Ian Bayles; Alister P W Funnell; Tyler E Miller; Alina Saiakhova; Michael M Lizardo; Cynthia F Bartels; Maaike Y Kapteijn; Stevephen Hung; Arnulfo Mendoza; Gursimran Dhillon; Daniel R Chee; Jay T Myers; Frederick Allen; Marco Gambarotti; Alberto Righi; Analisa DiFeo; Brian P Rubin; Alex Y Huang; Paul S Meltzer; Lee J Helman; Piero Picci; Henri H Versteeg; John A Stamatoyannopoulos; Chand Khanna; Peter C Scacheri
Journal:  Nat Med       Date:  2018-01-15       Impact factor: 53.440

  10 in total
  3 in total

1.  Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.

Authors:  Zhiqiang Liu; Guorong Zhang; Changlei Zhao; Juming Li
Journal:  Med Sci Monit       Date:  2018-07-27

2.  Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2.

Authors:  Cheryl A London; William P D Hendricks; Heather L Gardner; Karthigayini Sivaprakasam; Natalia Briones; Victoria Zismann; Nieves Perdigones; Kevin Drenner; Salvatore Facista; Ryan Richholt; Winnie Liang; Jessica Aldrich; Jeffrey M Trent; Peter G Shields; Nicholas Robinson; Jeremy Johnson; Susan Lana; Peter Houghton; Joelle Fenger; Gwendolen Lorch; Katherine A Janeway
Journal:  Commun Biol       Date:  2019-07-19

3.  MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712.

Authors:  Yifan Yu; Wenshan Zuo; Wei Cai; Yong Xu; Weidong Liu; Zexue Zhao
Journal:  Cancer Manag Res       Date:  2021-03-10       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.